Cargando…

486. Characteristics Associated with SARS-CoV-2 Infection in Children

BACKGROUND: We sought to describe the range of Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in children. METHODS: Patients < 18 years of age who had a positive nasopharyngeal polymerase chain reaction (PCR) for SARS-CoV-2 at a single health system in central Pennsylvania from 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Curtis Sudbury, F, Williams, Amanda, Kwon, Michelle, Musser, Leah, Gavigan, Patrick, Ericson, Jessica E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643884/ http://dx.doi.org/10.1093/ofid/ofab466.685

Ejemplares similares

1133. Opportunities for Antibiotic Discontinuation and De-escalation after Discharge from the Emergency Department in Pediatric Patients with UTI
por: Hawkins, Stephanie, et al.
Publicado: (2021)

486. Understanding Public Perception of COVID-19 Social Distancing on Twitter
por: Saleh, Sameh N, et al.
Publicado: (2020)

58. Clinical Characteristics of SARS-CoV-2 Among Confirmed and Suspected Cases in Tennessee
por: Talj, Rana, et al.
Publicado: (2020)

368. Performance Characteristics of Sequencing Assays for Identification of the SARS-CoV-2 Viral Genome
por: Antaki, Danny, et al.
Publicado: (2021)

370. Examining the Relationship Between SARS-CoV-2 PCR Cycle Threshold, Disease Severity and Epidemiologic Trends
por: Penney, Jessica, et al.
Publicado: (2021)

354. SARS-CoV-2 Viral Viability Culture and Sequencing from Immunocompromised Patients with Persistently Positive SARS-CoV-2 PCR Results
por: Sung, Abby, et al.
Publicado: (2021)

422. Impact of Respiratory Virus Co-Infection in Pediatric COVID-19
por: Mareboina, Manvita, et al.
Publicado: (2023)

283. Population-Based Co-infection of Carbapenem-Resistant Organisms and SARS-CoV-2 in Massachusetts
por: Geoghegan, Ashley, et al.
Publicado: (2021)

441. Clinical Characteristics of Pediatric SARS-CoV-2 Infection and Coronavirus Disease 2019 (COVID-19) in Kuwait
por: Alsharrah, Danah Y, et al.
Publicado: (2020)

390. Can Testing the Environment for SARS-CoV-2 Be a Signal for Staff Infections in Nursing Homes (NHs)?
por: Gussin, Gabrielle, et al.
Publicado: (2021)

486. Plasmid DNA Constructs Expressing SARS-CoV Antigens Are Immunogenic in Mice and Rabbits
Publicado: (2004)

431. SARS-CoV-2 Environmental Contamination in Hospitalized COVID-19 Patients’ Rooms
por: Warren, Bobby G, et al.
Publicado: (2021)

513. Use of Antimicrobial Stewardship Program in Operationalizing Monoclonal Antibody Therapy in SARS-CoV-2 Infection
por: Abrantes-Figueiredo, Jessica, et al.
Publicado: (2021)

358. Sociodemographic and clinical features of children and adolescents with SARS-CoV-2 infection in Nashville, Tennessee
por: Howard, Leigh, et al.
Publicado: (2020)

560. Repurposing Eravacycline for the Treatment of SARS-CoV-2 Infections
por: Reig, Núria, et al.
Publicado: (2020)

491. Persistence of SARS-CoV-2 Iinfection in Immunocompromised Children
por: Dolan, Susan, et al.
Publicado: (2021)

380. Environmental Contamination with SARS-CoV-2 in Nursing Homes
por: Mody, Lona, et al.
Publicado: (2021)

367. Clinical Characteristics and Outcomes in Patients with Pneumonia secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: Nichols, Courtney, et al.
Publicado: (2020)

418. Comparison of the Abbott SARS-CoV-2 IgG and DiaSorin LIASON SARS-CoV-2 S1/S2 IgG Antibody Assays
por: Schaack, Grace A, et al.
Publicado: (2020)

411. Application of a SARS-CoV-2-specific serologic assay for translational research and surveillance
por: Sherman, Amy C, et al.
Publicado: (2020)

466. SARS-CoV-2 Diagnosis And Point Prevalence in a Non-Cohorted Tertiary Care Center
por: Schrank, Spencer, et al.
Publicado: (2020)

378. Descriptive Analysis of SARS-CoV-2 Infections Among Health System and University Employees
por: Seidelman, Jessica, et al.
Publicado: (2021)

502. Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab
por: Gupta, Anil K, et al.
Publicado: (2021)

373. Comparison of the Epidemiology and Pathogens Cultured from Patients Hospitalized with SARS-CoV-2 Positive versus SARS-CoV-2 Negative in the US: A Multicenter Evaluation
por: Puzniak, Laura A, et al.
Publicado: (2020)

564. SARS-CoV-2 Ferritin Nanoparticle Vaccines Elicit Broad SARS Coronavirus Immunogenicity
por: Joyce, M G, et al.
Publicado: (2021)

443. Comparison of Clinical Characteristics of Endemic vs. SARS-CoV-2 Coronavirus Infection in Patients Admitted to a Community Teaching Hospital
por: Politis, Paula Ann, et al.
Publicado: (2020)

520. Longitudinal Analysis of SARS-CoV-2 Viruses in Hospitalized Adults
por: Simons, Lacy, et al.
Publicado: (2020)

513. Viral kinetics of SARS-CoV-2 in patients with COVID-19
por: Kim, Da Young, et al.
Publicado: (2020)

301. Detection of Pneumococcal Pneumonia During SARS-CoV-2 Infection
por: Watkins, Anne, et al.
Publicado: (2021)

372. Detection of SARS-CoV-2 RNAemia in Deceased Tissue Donors
por: Greenwald, Melissa, et al.
Publicado: (2021)

1172. SARS-CoV-2 Vaccine Hesitancy in Caregivers of Hospitalized Children
por: Orbea, Marisa, et al.
Publicado: (2021)

579. Design and Immunogenicity of a Pan-SARS-CoV-2 Synthetic DNA Vaccine
por: Schultheis, Katherine, et al.
Publicado: (2021)

363. Characteristics of Envelope and Nuclear Gene Expression Patterns in Asymptomatic SARS-CoV-2 Patients: A Single Center Retrospective Observational Study
por: Mizuno, Keiko, et al.
Publicado: (2021)

290. Persistence of Long COVID in SARS-CoV-2 Confirmed Cases One-Year Post Infection
por: Howe, Harrison L, et al.
Publicado: (2021)

484. The Impact of SARS-CoV-2 on Reproduction Rates of Seasonal Influenza and RSV
por: Sherman, Amy C, et al.
Publicado: (2020)

412. Assessment and Capability of SARS-CoV-2 Detection in the Veterans Health Administration
por: Sharma, Aditya, et al.
Publicado: (2020)

359. Clinical implications of SARS-CoV-2 PCR presumptive positive results
por: Yamamoto, Takeru, et al.
Publicado: (2021)

554. Clinical Impact of Monoclonal Antibody Therapy with SARS-CoV-2 Infection
por: Mann, Inderjit, et al.
Publicado: (2021)

453. Neutralizing Antibody Responses to SARS-CoV-2 in Professional Soccer Players
por: Pagura, Jorge, et al.
Publicado: (2021)

487. Experience with Remdesivir for Treatment of SARS-CoV-2 in Patients with Liver Cirrhosis
por: Saunders-Hao, Patricia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_810nufptcejq4jkj2t0e5cvb2f